Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums

User menu

  • My alerts

Search

  • Advanced search
The College of Family Physicians of Canada
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums
  • My alerts
The College of Family Physicians of Canada

Advanced Search

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • RSS feeds
  • Follow cfp Template on Twitter
Research ArticlePractice

Screening for depressive symptoms

Asnat Walfisch, Corey Sermer, Ilan Matok, Gideon Koren and Adrienne Einarson
Canadian Family Physician July 2011, 57 (7) 777-778;
Asnat Walfisch
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Corey Sermer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ilan Matok
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gideon Koren
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adrienne Einarson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • CFPlus
  • eLetters
  • Info & Metrics
  • PDF
Loading

Abstract

Question Several of my female patients of reproductive age seem to be depressed. Is there a simple tool I can use to screen them?

Answer Motherisk is using the Edinburgh Postnatal Depression Scale to screen for depression. This simple questionnaire is filled out by women while in the waiting room. Using this tool has helped us identify large numbers of women who are at risk of, but have not been diagnosed with, depression. We believe family physicians should use this screening tool extensively with women of reproductive age.

Recent studies suggest that at least 10% of all pregnant women meet the criteria for major depression,1 and up to 18% exhibit elevated depressive symptoms.2 Untreated depression in pregnancy has been associated with poor maternal health and adverse pregnancy outcomes. The Edinburgh Postnatal Depression Scale (EPDS)* is a 10-item self-rating scale. It was developed by Cox et al in 1987 for detection of postpartum depression3 and was later validated for use during pregnancy.4 Scores range from 0 to 30, with a cutoff score of 11 or higher being recommended for need of monitoring of major and minor depressive disorder. Although not diagnostic per se, a cutoff score of 14 or higher is recommended for detection of major depressive disorder, with sensitivities of up to 100%.5 Owing to our growing awareness of the fact that many women with depression go undiagnosed, in 2007 Motherisk added the EPDS to our routine assessment in the clinic. Women complete the questionnaire while in our clinic waiting for their appointments. Following the appointment, we report the EPDS results to the patient and follow the appropriate recommendations (Box 1).

Upon analyzing the outcomes from the first 2.5 years of using this assessment, we were very surprised by the findings and clinical implications. From October 2007 to April 2010, 404 women completed the questionnaire, 176 (43.6%) of whom were pregnant at the time. Overall, a quarter of the women (25.7%, 104 of 404) received a score of 13 or higher on the EPDS scale, which is highly suggestive of major depressive disorder.

Box 1.

Recommended follow-up to results of the Edinburgh Postnatal Depression Scale (EPDS)*: The EPDS is a 10-item self-rating scale. The total score is calculated by adding together the scores of the 10 items; maximum score is 30.

Recommended follow-up to results of the EPDS* is as follows
  • A score of 1–3 on item 10† indicates a risk of self-harm and requires immediate mental health assessment and intervention as appropriate

  • A score in the range of 11–13 indicates need for monitoring, support, and education

  • A score of ≥ 14 indicates need for follow-up with biopsychosocial diagnostic assessment for depression

  • ↵* The EPDS is available at www.cfp.ca. Go to the full text of this article online, then click on CFPlus in the menu at the top right-hand side of the page.

  • ↵† Item 10 on the EPDS is as follows: The thought of harming myself has occurred to me “yes, quite often,” “sometimes,” “hardly ever,” or “never.” The top box (ie, “yes, quite often”) is scored as 3 and the bottom box (ie, “never”) is scored as 0.

  • Forty-three percent of the pregnant subpopulation (75 of 176) scored 11 or higher on the EPDS scale, and nearly a third (31.2%, 55 of 176) scored 14 or higher. Most of these women came to our clinic for counseling on conditions unrelated to depression. For the final statement on the EPDS (ie, The thought of harming myself has occurred to me “yes, quite often,” “sometimes,” hardly ever,” or “never”), 32.0% (24 of 75) of women chose responses other than “never.” One hundred fifty-seven women came to the clinic for counseling specifically regarding antidepressant medications. Of these diagnosed and treated women, 32.5% scored 13 or higher.

    It is alarming that a large number of women in our population, not previously diagnosed with depression, appear to be exhibiting depressive symptoms and occasional suicidal thoughts. In addition we noted that a substantial number of women currently treated pharmacologically for depression also scored high on the EPDS scale, suggesting undertreatment. These results strongly support implementing this depression-screening tool as part of a routine medical investigation during early pregnancy, in an effort to identify, monitor, and treat these women.

    Notes

    Motherisk

    Motherisk questions are prepared by the Motherisk Team at the Hospital for Sick Children in Toronto, Ont. Mr Sermer was a summer student at Motherisk. Drs Walfisch and Matok are members of the Motherisk Program. Dr Koren is Director of the Motherisk Program. Ms Einarson is a consultant for the Motherisk Program. Dr Koren is supported by the Research Leadership for Better Pharmacotherapy during Pregnancy and Lactation. He holds the Ivey Chair in Molecular Toxicology in the Department of Medicine at the University of Western Ontario in London.

    Do you have questions about the effects of drugs, chemicals, radiation, or infections in women who are pregnant or breastfeeding? We invite you to submit them to the Motherisk Program by fax at 416 813-7562; they will be addressed in future Motherisk Updates.

    Published Motherisk Updates are available on the Canadian Family Physician website (www.cfp.ca) and also on the Motherisk website (www.motherisk.org).

    Footnotes

    • ↵* The Edinburgh Postnatal Depression Scale is available at www.cfp.ca. Go to the full text of this article online, then click on CFPlus in the menu at the top right-hand side of the page.

    • Competing interests

      None declared

    • Copyright© the College of Family Physicians of Canada

    References

    1. ↵
      1. Einarson A
      . Introduction: reproductive mental health—Motherisk update 2008. Can J Clin Pharmacol 2009;16(1):e1-5. Epub 2009 Jan 22.
      OpenUrlPubMed
    2. ↵
      1. Muzik M,
      2. Marcus SM,
      3. Heringhausen JE,
      4. Flynn H
      . When depression complicates childbearing: guidelines for screening and treatment during antenatal and postpartum obstetric care. Obstet Gynecol Clin North Am 2009;36(4):771-88, ix-x.
      OpenUrlCrossRefPubMed
    3. ↵
      1. Cox JL,
      2. Holden JM,
      3. Sagovsky R
      . Detection of postnatal depression. Development of the 10-item Edinburgh postnatal depression scale. Br J Psychiatry 1987;150:782-6.
      OpenUrlAbstract/FREE Full Text
    4. ↵
      1. Chatillon O,
      2. Even C
      . Antepartum depression: prevalence, diagnosis and treatment [article in French]. Encephale 2010;36(6):443-51. Epub 2010 Apr 7.
      OpenUrlPubMed
    5. ↵
      1. Chaudron LH,
      2. Szilagyi PG,
      3. Tang W,
      4. Anson E,
      5. Talbot NL,
      6. Wadkins HI,
      7. et al
      . Accuracy of depression screening tools for identifying postpartum depression among urban mothers. Pediatrics 2010;125(3):e609-17. Epub 2010 Feb 15.
      OpenUrlAbstract/FREE Full Text
    PreviousNext
    Back to top

    In this issue

    Canadian Family Physician: 57 (7)
    Canadian Family Physician
    Vol. 57, Issue 7
    1 Jul 2011
    • Table of Contents
    • About the Cover
    • Index by author
    Print
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for your interest in spreading the word on The College of Family Physicians of Canada.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Screening for depressive symptoms
    (Your Name) has sent you a message from The College of Family Physicians of Canada
    (Your Name) thought you would like to see the The College of Family Physicians of Canada web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Screening for depressive symptoms
    Asnat Walfisch, Corey Sermer, Ilan Matok, Gideon Koren, Adrienne Einarson
    Canadian Family Physician Jul 2011, 57 (7) 777-778;

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Respond to this article
    Share
    Screening for depressive symptoms
    Asnat Walfisch, Corey Sermer, Ilan Matok, Gideon Koren, Adrienne Einarson
    Canadian Family Physician Jul 2011, 57 (7) 777-778;
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • Abstract
      • Notes
      • Footnotes
      • References
    • Figures & Data
    • CFPlus
    • Info & Metrics
    • eLetters
    • PDF

    Related Articles

    • PubMed
    • Google Scholar

    Cited By...

    • No citing articles found.
    • Google Scholar

    More in this TOC Section

    Practice

    • Managing type 2 diabetes in primary care during COVID-19
    • Effectiveness of dermoscopy in skin cancer diagnosis
    • Spontaneous pneumothorax in children
    Show more Practice

    Motherisk Update

    • Hepatitis A infection during pregnancy
    • Fluconazole use during breastfeeding
    • Is it safe to breastfeed while taking methylphenidate?
    Show more Motherisk Update

    Similar Articles

    Navigate

    • Home
    • Current Issue
    • Archive
    • Collections - English
    • Collections - Française

    For Authors

    • Authors and Reviewers
    • Submit a Manuscript
    • Permissions
    • Terms of Use

    General Information

    • About CFP
    • About the CFPC
    • Advertisers
    • Careers & Locums
    • Editorial Advisory Board
    • Subscribers

    Journal Services

    • Email Alerts
    • Twitter
    • RSS Feeds

    Copyright © 2021 by The College of Family Physicians of Canada

    Powered by HighWire